Literature DB >> 21221096

The problems with today's pharmaceutical business--an outsider's view.

Mark Kessel1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21221096     DOI： 10.1038/nbt.1748

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Pfizer explores rare disease path.

Authors:  Catherine Shaffer
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  Drug giants turn their backs on RNA interference.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962
  2 in total
  13 in total

Review 1.  The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group.

Authors:  Susanna Wu-Pong; Jogarao Gobburu; Stephen O'Barr; Kumar Shah; Jason Huber; Daniel Weiner
Journal:  Am J Pharm Educ       Date:  2013-05-13       Impact factor: 2.047

2.  Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.

Authors:  Richard S Rogers; Nancy S Nightlinger; Brittney Livingston; Phil Campbell; Robert Bailey; Alain Balland
Journal:  MAbs       Date:  2015-07-17       Impact factor: 5.857

3.  The changing face of corporate venturing in biotechnology.

Authors:  Georg von Krogh; Boris Battistini; Fotini Pachidou; Pius Baschera
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

Review 4.  The role of brain tumor advocacy groups.

Authors:  Michele Rhee; Paulius Mui; Carl Cadogan; Jonny Imerman; Sarah Lindsell; Lainey Titus Samant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 5.  Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority.

Authors:  Ying Yuan; J Jack Lee; Susan G Hilsenbeck
Journal:  JCO Precis Oncol       Date:  2019-10-24

6.  Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione.

Authors:  Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2015-03-16       Impact factor: 3.739

Review 7.  Macroscopic modeling of mammalian cell growth and metabolism.

Authors:  Bassem Ben Yahia; Laetitia Malphettes; Elmar Heinzle
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-22       Impact factor: 4.813

Review 8.  Opening the door to innovation.

Authors:  Janine Schuurman; Yvo F Graus; Aran F Labrijn; Sigrid Ruuls; Paul W H I Parren
Journal:  MAbs       Date:  2014-04-24       Impact factor: 5.857

Review 9.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

10.  Biosimilars: company strategies to capture value from the biologics market.

Authors:  Bruno Calo-Fernández; Juan Leonardo Martínez-Hurtado
Journal:  Pharmaceuticals (Basel)       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.